-transparent.png){kind=logo}
Erythrocyte aldehyde dehydrogenase activity (EALDH) was measured in 21 diabetics on long-term chlorpropamide therapy. Median EALDH was 0.362 units, range 0.108 to 0.750 units and correlated neither with previously assessed chlorpropamide alcohol flushing nor with coincident plasma or erythrocyte chlorpropamide concentration. The hypothesis that genetic or permanently acquired reduction in EALDH correlates with CPAF status was not supported. There was no concentration-related inhibition of the enzyme by prevailing plasma or erythrocyte chlorpropamide.
Related Publications
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
November 1986,
Clinical science (London, England : 1979),
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
January 1983,
European journal of clinical pharmacology,
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
February 1981,
Lancet (London, England),
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
October 1981,
British medical journal (Clinical research ed.),
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
October 1984,
Clinical science (London, England : 1979),
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
September 1982,
British medical journal (Clinical research ed.),
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
November 1984,
Diabetes research (Edinburgh, Scotland),
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
February 1985,
Israel journal of medical sciences,
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
January 1984,
Diabetologia,
R M Hillson, and
H H Ting, and
R F Smith, and
C S Yajnik, and
J Crabbe, and
T D Hockaday
December 1987,
Alcoholism, clinical and experimental research,
